Yuval Shaked
Technion - Israel Institute of Technology
H-index: 60
Asia-Israel
Top articles of Yuval Shaked
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy | Frontiers in Immunology | Jair Bar Raya Leibowitz Niels Reinmuth Astrid Ammendola Eyal Jacob | 2024/2/29 |
Interferon-stimulated neutrophils as a predictor of immunotherapy response | Cancer Cell | Madeleine Benguigui Tim J Cooper Prajakta Kalkar Sagie Schif-Zuck Ruth Halaban | 2024/2/12 |
Cancer treatment by blocking host-induced IL-1 in combination with radiotherapy | 2024/4/2 | ||
A subset of neutrophils as a predictive biomarker for immunotherapy response in patients with non–small-cell lung cancer and melanoma. | Yuval Shaked Madeleine Benguigui Ruth Halaban Antonella Bacchiocchi Iris Kamer | 2023/6/1 | |
Methods for treating acute respiratory inflammatory conditions and cytokine storm syndrome | 2023/5/25 | ||
Chemotherapy-induced tumor immunogenicity is mediated in part by megakaryocyte-erythroid progenitors | Oncogene | Avital Vorontsova Tim J Cooper Jozafina Haj-Shomaly Madeleine Benguigui Sapir Levin | 2023/3/3 |
The role of host response to chemotherapy: resistance, metastasis and clinical implications | Abhilash Deo Jonathan P Sleeman Yuval Shaked | 2023/11/24 | |
Oncogenic ASPM is a regulatory hub of developmental and stemness signaling in cancers | Kelvin K Tsai Byoung-Il Bae Chung-Chi Hsu Li-Hsin Cheng Yuval Shaked | 2023/9/15 | |
Predicting immunotherapy response | 2023/8/24 | ||
Longitudinal plasma proteomic profiling of patients with non-small cell lung cancer undergoing immune checkpoint blockade | Journal for Immunotherapy of Cancer | Michal Harel Coren Lahav Eyal Jacob Nili Dahan Itamar Sela | 2022 |
Method of treating cancer with an immune checkpoint inhibitor in combination with another therapeutic agent | 2022/6/23 | ||
Personalized approach for response prediction and treatment management for non-small cell lung cancer patients based on a liquid biopsy. | Yuval Shaked Michal Harel Coren Lahav Ben Yellini Ella Tepper | 2022/6/1 | |
Long-term Immunogenicity of BNT162b2 vaccine in patients with solid tumors | JAMA oncology | Ithai Waldhorn Roy Holland Tal Goshen-Lago Madeleine Benguigui Michael Halberthal | 2022/6/1 |
RNF4~ RGMb~ BMP6 axis required for osteogenic differentiation and cancer cell survival | Cell Death & Disease | Rostislav Novak Yamen Abu Ahmad Michael Timaner Eliya Bitman-Lotan Avital Oknin-Vaisman | 2022/9/24 |
Photopharmacological modulation of native CRAC channels using azoboronate photoswitches | Proceedings of the National Academy of Sciences | Ronald Udasin Anwesha Sil Elia Zomot Hadas Achildiev Cohen Jozafina Haj | 2022/3/29 |
Harnessing the therapeutic power of secretomes to treat IPF | M Timaner T Fishman-Jacob B Pertzov B Tadmor J Laufer | 2022/9/4 | |
T cells promote metastasis by regulating extracellular matrix remodeling following chemotherapy | Cancer research | Jozafina Haj-Shomaly Avital Vorontsova Tamar Barenholz-Cohen Oshrat Levi-Galibov Mahesh Devarasetty | 2022/1/15 |
Bv8 blockade sensitizes Anti-PD1 therapy resistant tumors | Frontiers in Immunology | Madeleine Benguigui Avital Vorontsova Michael Timaner Sapir Levin Jozafina Haj-Shomaly | 2022/7/7 |
Integration of proteomic and clinical data for the prediction of response to immune checkpoint inhibitor therapy in non-small cell lung cancer. | Yuval Shaked Michal Harel Coren Lahav Eyal Jacob Itamar Sela | 2021/5/20 | |
Metronomic chemotherapy modulates clonal interactions to prevent drug resistance in non-small cell lung cancer | Cancers | Maryna Bondarenko Marion Le Grand Yuval Shaked Ziv Raviv Guillemette Chapuisat | 2021/5/7 |
Co-Authors
